GFM
PLRX icon

GF Fund Management’s Pliant Therapeutics PLRX Stock Holding History

GF Fund Management’s Portfolio PLRX Stock Details PLRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-1,264
Closed -$1.87K – 687
2025
Q3 		$1.87K Sell
1,264
-245
-16% -$374 ﹤0.01% 624
2025
Q2 		$1.75K Hold
1,509
– – ﹤0.01% 650
2025
Q1 		$2.04K Buy
1,509
+231
+18% +$1.4K ﹤0.01% 648
2024
Q4 		$16.8K Buy
+1,278
New +$17.4K ﹤0.01% 487

Other funds holding PLRX

TCM
Tang Capital Management San Diego, California $2.2B AUM 156.35% 1-Year Est. Return
BOCH
Blue Owl Capital Holdings New York $665M AUM 95.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.91% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return
WP
Woodline Partners San Francisco, California $32.4B AUM 58.5% 1-Year Est. Return
MAM
Monaco Asset Management Monaco $1.26B AUM 60.23% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.49B AUM 208.7% 1-Year Est. Return
PM
Prosight Management Dallas, Texas $580M AUM 29.81% 1-Year Est. Return
BCM
BML Capital Management Zionsville, Indiana $176M AUM 123.21% 1-Year Est. Return

GF Fund Management's PLRX Position: Q4 2025 in Review

GF Fund Management sold out of Pliant Therapeutics (PLRX) in Q4 2025, closing a stake of 1,264 shares — an estimated $1.87K sold.

GF Fund Management first reported a position in PLRX in Q4 2024 and held it in 4 quarters. The position peaked at $16.8K in Q4 2024. 97 funds tracked by Wall St. Rank hold PLRX as of Q4 2025.

  • GF Fund Management reported no remaining Pliant Therapeutics position as of Q4 2025 after selling out during the quarter.
  • GF Fund Management sold 1,264 Pliant Therapeutics shares in Q4 2025, an estimated $1.87K.
  • GF Fund Management first reported a position in Pliant Therapeutics in Q4 2024 and held it in 4 quarters.
  • GF Fund Management's Pliant Therapeutics position peaked at $16.8K in Q4 2024.
  • 97 funds tracked by Wall St. Rank held Pliant Therapeutics as of Q4 2025.

Based on GF Fund Management's 13F filing for Q4 2025, filed 27 Jan 2026.